For instance, QDs labeled with epidermal growth factor receptor (EGFR) antibodies selectively bind glioblastoma and oligodendroglioma tissues overexpressing the EGFR, allowing a single-cell-level visualization and precise tumor boundary demarcation. Here, EGFR is linked to oligodendroglioma.